Cargando…
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046624/ https://www.ncbi.nlm.nih.gov/pubmed/33517606 http://dx.doi.org/10.3350/cmh.2021.0019 |
_version_ | 1783678887720386560 |
---|---|
author | Yip, Terry Cheuk-Fung Wong, Grace Lai-Hung Wong, Vincent Wai-Sun |
author_facet | Yip, Terry Cheuk-Fung Wong, Grace Lai-Hung Wong, Vincent Wai-Sun |
author_sort | Yip, Terry Cheuk-Fung |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8046624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-80466242021-04-22 Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact Yip, Terry Cheuk-Fung Wong, Grace Lai-Hung Wong, Vincent Wai-Sun Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2021-04 2021-02-01 /pmc/articles/PMC8046624/ /pubmed/33517606 http://dx.doi.org/10.3350/cmh.2021.0019 Text en Copyright © 2021 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Yip, Terry Cheuk-Fung Wong, Grace Lai-Hung Wong, Vincent Wai-Sun Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title | Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title_full | Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title_fullStr | Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title_full_unstemmed | Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title_short | Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact |
title_sort | negligible risk of hepatocellular carcinoma in chronic hepatitis b patients in immune-tolerant phase: myth or fact |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046624/ https://www.ncbi.nlm.nih.gov/pubmed/33517606 http://dx.doi.org/10.3350/cmh.2021.0019 |
work_keys_str_mv | AT yipterrycheukfung negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact AT wonggracelaihung negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact AT wongvincentwaisun negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact |